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Vetsuisse Faculty, Institute of Veterinary Pathology, Zürich, Switzerland, 3 Laboratorio Nacional de
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Abstract
In humans, orthohantaviruses can cause hemorrhagic fever with renal syndrome (HFRS) or
hantavirus pulmonary syndrome (HPS). An earlier study reported that acute Andes virus
HPS caused a massive and transient elevation in the number of circulating plasmablasts
with specificity towards both viral and host antigens suggestive of polyclonal B cell activa-
tion. Immunoglobulins (Igs), produced by different B cell populations, comprise heavy and
light chains; however, a certain amount of free light chains (FLCs) is constantly present in
serum. Upregulation of FLCs, especially clonal species, associates with renal pathogenesis
by fibril or deposit formations affecting the glomeruli, induction of epithelial cell disorders, or
cast formation in the tubular network. We report that acute orthohantavirus infection
increases the level of Ig FLCs in serum of both HFRS and HPS patients, and that the
increase correlates with the severity of acute kidney injury in HFRS. The fact that the kappa
to lambda FLC ratio in the sera of HFRS and HPS patients remained within the normal
range suggests polyclonal B cell activation rather than proliferation of a single B cell clone.
HFRS patients demonstrated increased urinary excretion of FLCs, and we found plasma
cell infiltration in archival patient kidney biopsies that we speculate to contribute to the
observed FLC excreta. Analysis of hospitalized HFRS patients’ peripheral blood mononu-
clear cells showed elevated plasmablast levels, a fraction of which stained positive for Puu-
mala virus antigen. Furthermore, B cells isolated from healthy donors were susceptible to
Puumala virus in vitro, and the virus infection induced increased production of Igs and FLCs.
The findings propose that hantaviruses directly activate B cells, and that the ensuing intense
production of polyclonal Igs and FLCs may contribute to acute hantavirus infection-associ-
ated pathological findings.
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Author summary
Orthohantaviruses are globally spread zoonotic pathogens, which can cause hemorrhagic
fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) with sig-
nificant burden to human health. The pathogenesis mechanisms of orthohantavirus-
caused diseases are not known in detail; however, excessive immune response towards the
virus with concomitant pathological effects against host tissues appears to be a contribut-
ing factor. Here we report an increase of free immunoglobulin (Ig) light chains (FLCs),
components required to make complete Ig molecules, in blood of acute HFRS and HPS.
Samples collected during acute HFRS demonstrated increased FLCs levels in the urine
and blood of patients hospitalized due the disease. Furthermore, the FLC levels positively
correlated with markers of acute kidney injury. In addition, our results show that ortho-
hantaviruses can infect and activate B cells to produce FLCs as well as whole Igs, which
provides a mechanistic explanation of the increased FLC levels in patients. Taken
together, our results suggest that aberrant antibody responses might play a role in the
pathogenesis of orthohantavirus infections.
Introduction
The pathogenicity of zoonotic viruses often links to the mechanisms the virus employs to fight
host immune system [1]. Orthohantaviruses, a genus of rodent-, insectivore- and bat-borne
viruses, cause a persistent and seemingly benign infection in their reservoir hosts [2]. Zoonotic
transmission of rodent-borne orthohantaviruses occurs via aerosolized rodent excreta and
may lead to hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syn-
drome (HPS). The incubation period for HFRS ranges from ten days to six weeks and the
infection starts with fever accompanied by headache, abdominal and back pains, nausea and
vomiting. Increased vascular leakage can result in fluid accumulation in various tissues and
sometimes hypotension and shock. Thrombocytopenia and leukocytosis are typical laboratory
findings [3]. Acute kidney injury (AKI) is common in hospital-treated patients. Renal involve-
ment includes oliguria, hematuria and proteinuria. Polyuric phase precede the recovery [4].
The severity of HFRS varies depending on the causative orthohantavirus, e.g., Hantaan virus
(HTNV) causes a severe- and Puumala virus (PUUV) a mild HFRS with respective case fatality
rates of ~5% and 0.08–0.4%. However, AKI is not a common finding in HPS, where fatality
rates can exceed 40% and the most affected organ is the lungs [2].
The kidney pathophysiology of HFRS remains elusive. The marked proteinuria associated
with HFRS is of both glomerular and tubular origin, indicating acute failure in glomerular
sieving and tubular re-absorptive functions [4]. Histological analysis reveals that the glomeru-
lar apparatus remains relatively intact, but tubular epithelial cells can show even necrosis [4].
A common histopathological finding is acute tubulointerstitial nephritis (ATIN) with infiltra-
tion of various immune cells, and elevated levels of cytokines as well as adhesion molecules fur-
ther imply an immune-mediated pathogenesis [5,6]. Orthohantaviruses target mainly
endothelial cells lining the vasculature [3,7]. However, the virus also infects renal tubular epi-
thelial cells, as demonstrated by histology of acute HFRS patients and experimentally infected
macaques [8]. As the transmission to humans occurs via inhalation of aerosolized rodent
excreta [2]. The lungs are the initial target organ of the virus and infection of endothelial cells
lining the bloodstream is the probable route of spread to the kidneys and other parts of the
body [2]. The reasons for the long incubation period between infection and appearance of
symptoms remains unknown.
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In a recent report, we described how PUUV infection gave rise to free light chains (FLCs)
capable of binding viral N protein [9]. These findings prompted us to study whether overpro-
duction of FLCs occurs in acute hantavirus infection, together with the possible association
between excess FLCs and HFRS-associated AKI. Because circulating activated B cells presum-
ably produce FLCs [10,11], we further analyzed the ability of PUUV to infect and activate B
cells both in vitro and in patients.
Materials and methods
Ethics statement and clinical samples
The Ethics Committees of Tampere University Hospital (permit numbers 99256 and R04180)
and Comité de Etica en Investigación—ANLIS “Dr. C. Malbrán” (FOCANLIS 2015–1532)
approved the use of patient samples. All subjects gave a written informed consent in accor-
dance with the Declaration of Helsinki. The study material consisted of peripheral blood
mononuclear cells (PBMCs), serum, plasma, and urine from hospitalized, serologically con-
firmed acute PUUV infection at Tampere University Hospital, Finland, between September
2000 and March 2009. The samples were collected sequentially during hospitalization (acute
stage and during recovery convalescent stage). Sequential samples included PBMCs from 13 as
well as serum and urine from 14 patients (S1 Fig). Additionally, samples included serum col-
lected on the first hospitalization day of 56 patients (S1 Table). As references, serum from
patients with clinically suspected PUUV infection but serologically negative (from Helsinki
and Uusimaa Hospital District laboratory HUSLAB) as well as healthy controls were included
(n = 8 for both). In the case of HPS, serum samples from 54 cases (2–13 days after onset of
fever) and 10 healthy controls were used (S2 Table). The HPS cases were categorized in terms
of severity grades based on the classification employed in [12]: Grade 1, patients with prodro-
mal symptoms without respiratory involvement; Grade 2, patients with mild to moderate
respiratory compromise without hemodynamic compromise; Grade 3, patients with severe
respiratory insufficiency with hemodynamic compromise; Grade 4, patients with severe respi-
ratory insufficiency with refractory-to-treatment hemodynamic compromise and fatal out-
come. PBMC were stored in -135˚C, blood and urine samples in -80˚C prior to analysis.
The study included archival Bouin-fixed, paraffin-embedded kidney biopsies collected dur-
ing 1978–1989 at Tampere University Hospital (ethical permit number R18808, S3 Table). The
highest measured serum creatinine level of the patients ranged from 220 to 1,050 μmol/L. Cre-
atinine was determined by Cobas Integra (F. Hoffmann-La Roche Ltd.). National supervisory
authority of Health and Welfare approved the study on kidney biopsies (No. V/19454/2018).
Protein quantification
Immunoglobulin Free Light Chains Kappa and Lambda Human ELISA (Biovendor) served for
measuring FLCs in serum, plasma and urine of all study patients (all 1:200 dilution) and in B
cell culture supernatants (1:2 dilution for lambda, 1:5 for kappa). ELISA kits obtained from
Mabtech served for measuring total IgA, IgM and IgG levels from PUUV patient plasma and
from B cell culture supernatants. BCA assay kit (Thermo Scientific) served for measuring total
urinary protein solubilized in 5% SDS in 0.5 N NaOH after 10% trichloroacetic acid precipita-
tion and 70% ethanol washes. The determination of urine albumin (U-Alb) was made by an
immunoturbidometric method on a Cobas C 702 –clinical chemistry analyzer (F. Hoffman–La
Roche Ltd.). The excretion rate in the urine was calculated using the volume of urine collected
in a recorded timeframe (minutes).
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Immunohistochemistry
Paraffin-embedded kidney biopsies of patients with acute HFRS were stained with rabbit poly-
clonal κ or λ LC-specific antibodies (Dako) followed by polymer-based horseradish peroxidase
(HRP) chromogenic detection and hematoxylin counterstain. Biopsies from patients with
unrelated kidney disease served as the controls. The staining followed standard procedures of
Helsinki University diagnostic laboratory HUSLAB. Image digitalization was done with Zeiss
Axioscan slide scanner and enumeration of κ or λ LC-positive cells in relation to total cell
number was performed using Aiforia v4.8 cloud platform (Aiforia Technologies Oy, Helsinki,
Finland). The platform employs image-based artificial intelligence (AI) with high-performance
cloud computing to discriminate between HRP-positive and -negative cells in individual tis-
sues. The AI training process included ~2500 iterations based on ~500 annotations of manu-
ally selected positive and negative objects with visible nuclei.
Blood fractionation and B cell enrichment
Ficoll-Paque (GE Healthcare) served in isolation of peripheral blood mononuclear cells
(PBMCs) from EDTA-anticoagulated blood of PUUV patients and healthy volunteers or from
buffy coats obtained from the Finnish Red Cross Blood Service. The PBMC isolations followed
the protocol of Miltenyi Biotec. The obtained PBMCs were either frozen in -135˚C (as was the
case for all PUUV patient samples), used directly for in vitro infection experiments with
PUUV, or subjected to B cell enrichment through negative selection by EasySep™ Human Pan-
B Cell Enrichment Kit (Stemcell technologies). The enrichment routinely resulted in ~90%
purity of CD19+ B cells, as determined by flow cytometry.
Cell lines and viruses
PUUV (strain Kazan) was propagated in Vero E6 cells (African green monkey kidney epithe-
lial cell line; ATCC no. CRL-1586) grown in Minimum Essential Medium Eagle (MEM; Sigma
Aldrich) supplemented with 10% inactivated fetal calf serum (FCS), 100 IU/ml of penicillin,
100 μg/ml of streptomycin and 2 mM of L-glutamine. For infection experiments, the virus was
pelleted by ultracentrifugation (SW28 rotor, 27,000 rpm, 50 min, +4˚C) through a 0.22 μm-fil-
tered 30% ultra-pure sucrose cushion (in PBS), to obtain concentrated virus preparation free
of cell culture contaminants. The pellets suspended into Vero E6 cell growth medium showed
infectious PUUV titers of approximately 107 fluorescent focus-forming units (FFU)/ml as
described [6]. Where indicated, PUUV was inactivated with UV (300,000 μJ/cm2, Stratalinker,
Stratagene). For mock infections, an equal amount of conditioned cell culture supernatant was
subjected to ultracentrifugation and the pelleted material treated as described for PUUV
pellets.
In vitro infection experiments
PBMCs or enriched B cells were inoculated with mock medium, with purified PUUV, or UV-
inactivated PUUV (PUUV-UV) at multiplicity of infection (MOI) of 5, and incubated 5 days
at 37˚C, 5% CO2 in B cell growth medium. The B cells were maintained in RPMI-1640 (Sigma
Aldrich) supplemented with 10% inactivated FCS, 100 IU/ml of Penicillin and 100 μg/ml of
Streptomycin, 2 mM of L-glutamine, 20 ng/ml rIL-2 (recombinant interleukin-2, Immuno-
tools) and ITS cell culture supplement (Sigma-Aldrich). The cells were pelleted by centrifuga-
tion (400 x g, 10 min) and PBMCs subjected to flow cytometry analysis (described below) and
enriched B cells for immunofluorescence and western blot analyses.
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In the case of ELISA and Elispot experiments, B cells, enriched from PBMCs by negative
selection, were inoculated (1 h at 37˚C, 5% CO2) with mock medium, PUUV, PUUV-UV, Sen-
dai virus, or Sindbis virus at MOI of 1, all diluted in B cell growth medium. Non-infected cells
with added CpG (1 μM) served as positive control for B cell activation. The virus inoculum
was removed by pelleting the cells by centrifugation (400 x g, 10 min), and one million cells/ml
were incubated in B cell growth medium at 37˚C 5% CO2, for the times indicated in the figure
legends. After incubation, the cells were pelleted by centrifugation (400 x g, 10 min), superna-
tants collected for the determination of Igs by ELISA, and the cells processed for Elispot
analysis.
Immunofluorescence
B cells were attached to glass slides using cytospin (Shandon), fixed with 4% paraformaldehyde
(in PBS) for 10 min at RT, and stained for immunofluorescence detection of PUUV N protein,
with the use of a rabbit polyclonal anti-PUUV N-specific serum, followed by AlexaFluor594-
conjugated secondary Ab (ThermoScientific). Light chains were stained with polyclonal goat
anti-κLC and anti-λLC antibodies (2 μg/ml each; Southern Biotech), followed by Alexa-
Fluor488-conjugated secondary Ab (ThermoScientific). Cell nuclei were stained with Hoechst
33342.
Western blot
B cells were lysed in non-reducing Laemmli sample buffer, subjected to sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane by stan-
dard procedures. The blots were sequentially probed with mouse monoclonal Ab (5E1)
detecting PUUV N protein, rabbit anti-actin Ab and goat anti-κLC followed by appropriate
IRdye680- or IRdye800-conjugated secondary Abs (Li-Cor). The blots were visualized using
Odyssey infrared imaging system (Li-Cor).
Flow cytometry
Frozen PUUV patient PBMCs were thawed in a 37˚C water bath for 5 min, added dropwise to
RPMI-1640 (Sigma Aldrich) supplemented with 10% inactivated FCS, 100 IU/ml of penicillin,
100 μg/ml of streptomycin, 2mM of L-glutamine, and 100 μg/ml DNAse I (Sigma Aldrich).
After a 10 min incubation at RT, the cells were washed once with the conditioned medium
and once with PBS-EDTA (PBS with 1 mM EDTA), followed by cell quantification using Bio-
Rad cell counter TC20.
One to three million PBMCs or 250,000 B cells (enriched from PBMC fraction, see above)
were stained with fixable viability stain (FVS570, BD) for 15 min at RT. Then 1% FCS and FcR
Blocking reagent (Immunostep) were added, and the cells stained for 30 min at RT with a
cocktail of fluorescent-dye conjugated anti-human mouse mAbs recognizing cell surface anti-
gens. The cocktail included antibodies against: CD3 FITC (clone OKT3; Thermo Scientific),
CD56 FITC (B-A19) and CD66 FITC (6g5j; both from Immunotools), CD138 APC-Vio770
(44F9; Miltenyi), CD14 FITC (M5E2), CD38 PE-CF594 (HIT2), CD27 V500 (M-T271),
HLA-DR BV786 (G46-6) and CD19 BV711 (SJ25C1; all from BD). For some samples, CD19
PE-Cy5 (HIB19; Thermo Scientific) and IgD BV605 (IA6-2; BD) were used. The cells were
fixed, permeabilized (eBioscience fixation and permeabilization buffer; Thermo Scientific),
and stained with mAbs against intracellular antigens for 30 min at RT. The following mAbs
were used: anti-kappa light chain PercP-Cy5.5 (G20-193), anti-lambda light chain BV605
(JDC-12), anti-IgM APC (G20-127), anti-IgG AF700 (G18-145; all from BD) and anti-IgA
PE-Vio770 (IS11-8E10; Miltenyi). In the experiments with AF647-conjugated bank vole mAb
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recognizing PUUV N protein (1C12; [13,14]) the anti-IgM APC was replaced by anti-IgM
V450 (G20-127; BD). After staining, the cells were washed with PBS-EDTA and fixed with 1%
paraformaldehyde before FACS analysis with a three-laser (405, 488 and 640 nm) LSRII For-
tessa instrument (BD).
The FACS data was analyzed with FlowJo 10.6. The datasets were normalized indepen-
dently, concatenated and Uniform Manifold Approximation and Projection for Dimension
Reduction (UMAP) was performed for the unsupervised identification of cell populations and
dimensionality reduction [15], based on the detection of different fluorochromes used in the
flow cytometry panel. To generate UMAP plots, the minimum distance was set at 0.5 and the
nearest neighbors’ distance was set at 15, using a Euclidean vector space. Clusters were then
identified and described by performing a flow self-organizing map (flowSOM) [16] with a
number of meta-clusters set to 10.
Elispot
Elispot-assays, performed as described [17], served to detect IgA, IgM and IgG secreting cells.
Briefly, nitrocellulose filter plates (Millipore) were coated with polyclonal goat anti-κLC and
anti-λLC antibodies (10 μg/ml in PBS each; Southern Biotech) overnight at 4˚C. The plates
were blocked (2% skimmed milk in RPMI-1640) at RT for 1 h, before adding in vitro infected
washed B cells, at a 1:5 dilution in RPMI-1640 containing 0.5% BSA. After incubation (3 h at
37˚C), the plates were washed three times with PBS and four times with PBS-T (PBS+0.05%
Tween 20). The plates were then incubated (1 h at RT) with polyclonal (all goat, Southern Bio-
tech) AP-conjugated anti-IgA, HRP-conjugated anti-IgM, or HRP-conjugated anti-IgG anti-
bodies, washed three times with PBST and three washes with MilliQ water. IgA secreting cells
were detected using 5-Bromo-4-chloro-3-indolyl phosphate ρ-toluidine and nitroblue tetrazo-
lium chloride (BCP/NBIT) “ready to use” solution (Sigma Aldrich) and IgM and IgG secreting
cells using 3-amino-9-ethyl-carbazole (AEC). The AEC solution consisted of 400 μg/ml AEC
(Sigma Aldrich; 10 mg/ml stock solution in dimethylformamide) and 0.012% H2O2 in 0.1 M
acetate buffer (pH 5.0). AiD Elispot reader (AutoImmun Diagnostika) served for plate imaging
and spot counting.
Statistical analyses
GraphPad Prism 8.3 served to identify statistically significant differences between the treat-
ment groups. The specific tests used are indicated in the figure legends. General estimating
equations on SPSS v25 (IBM) was used to assess differences between sequential samples (the
acute vs. convalescent phase).
Results
Circulating FLCs increase in acute hantaviruses diseases
We recently reported that patients with acute PUUV infection possess FLCs specific to PUUV
N protein [9]. To study if hantavirus infection induces an overall increase in circulating κ and
λ FLC concentrations, we used ELISA to compare the serum samples of patients hospitalized
due to acute HFRS caused by PUUV and HPS caused by ANDV to those of patients suffering
from other febrile illness (OFI) and healthy volunteers. Both HFRS and HPS patients showed
significantly higher median concentrations of κFLC and λFLC (κFLC = 34.05 and 10.66; λFLC =
26.37 and 22.39 μg/ml, respectively) as compared to healthy volunteers (κFLC = 4.81 and λFLC
= 9.96 μg/ml) or patients with PUUV-suspected but serologically negative febrile illnesses
(κFLC = 7.35 and λFLC = 17.14 μg/ml). While the λFLC levels remained comparable, the HFRS
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patient sera showed a significant increase in the κFLC levels as compared to HPS patient sera
(Fig 1A and 1B). The higher κFLC levels further associated with significantly elevated κFLC/λFLC
ratios (median 1.39) in HFRS cases as compared to other sample groups (median ratios 0.44–
0.64; Fig 1C).
The levels of circulating FLCs associate with acute kidney injury in HFRS
Given that the serum κFLC/λFLC ratio increases due to impaired renal FLC clearance [18,19],
we studied if FLCs play a role in AKI by comparing the κFLC and λFLC levels to the maximum
serum creatinine levels measured during the hospital stay in patients with acute HFRS (1st day
of hospitalization). Indeed, both κFLC and λFLC levels positively correlated with the maximum
creatinine values (Fig 2A and 2B), suggesting that FLC levels could serve as prognostic indica-
tor in estimating the severity of AKI in PUUV-HFRS. The FLC levels correlated significantly
also with urinary albumin excretion but not with the extent of thrombocytopenia or with the
level of inflammation as indicated by maximum level of blood leukocyte count or maximum
interleukin (IL)-6. However, the κFLC/λFLC ratio did not significantly associate with serum cre-
atinine or any other of the analyzed variables (S2A Fig). In addition, HFRS patients with the
need of dialysis demonstrated significantly higher serum κFLC levels in than patients not
requiring dialysis (S3A Fig). In HPS, however, the amounts of serum κFLC and λFLC did not
associate with disease severity, as assessed by the level pulmonary and hemodynamic involve-
ment (S3B Fig).
To study the kinetics of FLC upregulation in HFRS, we measured their concentrations in
serum samples collected sequentially during hospitalization, and at convalescence. The results
displayed elevated median values of both FLCs in the acute stage, i.e. four to ten days after
onset of fever (aof), as compared to samples drawn at recovery (grouped as 11–30 and 31–50
days aof) (Fig 2C). Similarly to FLC levels, the serum creatinine levels remained high through-
out the acute stage up to 10 dpi (Spearman R = 0.824, p< 0.0001, n = 45 for λFLC; Spearman
R = 0.836, p< 0.0001, n = 45 for κFLC; Fig 2D). At the same time, κFLC/λFLC ratio showed high
levels in the early acute stage that gradually declined towards recovery (Fig 2D). The highest
deviations in the levels of circulating leukocytes and thrombocytes (the highest and the lowest,
respectively), as compared to normal range, were also observed in the early acute phase
Fig 1. Soluble FLCs increase in hantavirus diseases. The concentrations of FLCs (κ in A and λ in B) as well as their ratio (in C) were measured by ELISA from
serum samples of acute PUUV-caused HFRS (n = 30), ANDV-caused HPS (n = 50), other febrile illness (OFI; n = 8) and healthy volunteers (n = 18). The
medians of patients with acute PUUV infection and OFI were compared to medians of healthy volunteers by Kruskal-Wallis + Dunn’s multiple comparisons
test and significant differences reported as � = p< 0.05, �� = p< 0.01, ��� = p< 0.001 and ���� = p< 0.0001. The bars indicate medians + interquartile ranges.
https://doi.org/10.1371/journal.ppat.1009843.g001
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Fig 2. Soluble FLCs correlate with the extent of kidney injury in HFRS. (A and B) To assess the prognostic value of serum FLC levels for acute kidney
injury, the concentration of FLCs (κ in A and λ in B) in serum samples collected at first day of hospitalization from patients with acute PUUV-HFRS (n = 30)
were correlated to the maximum serum creatinine values measured during the hospital stay, using Spearman’s rank correlation coefficient. Non-linear
association between parameters is depicted by the red line. (C) The serum concentration of FLCs were measured in sequential serum samples obtained from
patients hospitalized due to PUUV-HFRS (total patient n = 13, n for individual time points depicted in S1 Fig) in acute stage (days 4–10 after onset of fever)
and convalescence (grouped as 11–30 and 31–50 days after onset of fever). From the same samples as in (C), two indicators of renal clearance function, serum
PLOS PATHOGENS Hantavirus infection induces free light chains
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009843 August 11, 2021 8 / 21
(Fig 2E). The data further suggest a strong link between the severity of AKI and the circulating
levels of both κFLC and λFLC. Instead, the κFLC/λFLC ratio and the severity of AKI showed no
correlation, suggesting that factors other than impaired renal clearance contribute to the
increased circulating FLCs levels during acute HFRS.
Kinetics of urinary FLCs during the course of PUUV-HFRS
To evaluate the renal clearance of FLCs during HFRS, we measured the urinary FLC levels in
samples collected from patients with acute PUUV infection during hospitalization and in
recovery. The highest urinary output of both κFLC and λFLC occurred in early acute stage and
was followed by gradual decline to normal, barely detectable, levels at recovery (>10 days aof,
Fig 3A). Interestingly, the λFLC but not the κFLC levels significantly followed the total urinary
protein output in urine (Spearman R = 0.33, p = 0.019, n = 51 for λFLC; Spearman R = 0.19,
p = 0.343, n = 51 for κFLC, S4 Fig), suggesting that proteinuria alone does not explain the uri-
nary κFLC level increase. Comparison of the serum and urine FLC levels over the course of
HFRS revealed a peak in urine FLC levels in the early acute stage (4–6 days aof, Fig 3B and 3C)
whereas a peak in serum FLC levels occurred in late acute stage (7–10 days aof, Fig 3B and
3C). The differential kinetics of urine vs. serum FLC levels was further highlighted by the
absence of correlation between urine and serum κFLC or λFLC levels (Spearman R = -0.132,
p = 0.430, n = 38 for κFLC and R = -0.049, p = 0.796, n = 38 for λFLC).
Elevated renal plasma cell infiltration during acute PUUV-HFRS
Abnormally elevated serum FLC levels and renal insufficiency often associate with plasma cell
disorders [20]. The identification of increased FLC levels in serum and urine of PUUV-HFRS
prompted us to study the possibility of plasma cell infiltration in patient kidneys. Therefore,
we performed immunohistochemistry using anti-κ and anti-λ chain antibodies on kidney
biopsies of acute PUUV-HFRS and unrelated renal disease patients to demonstrate the pres-
ence of plasma cells (S3 Table). The staining revealed significantly increased numbers of infil-
trating plasma cells of both κ (3.21% vs. 2.29% of all cells) and λ (1.71% vs. 0.73% of all cells)
LCs in acute PUUV-HFRS as compared to control patients (Fig 4A and 4B). Furthermore, the
creatinine and serum κ and λ (κ / λ) FLCs ratio, were plotted together in (D) as well as thrombocyte and leukocytes counts in (E). The medians ± interquartile
ranges are shown in (C, D, E). The dotted lines indicate normal range limits for different parameters (24).
https://doi.org/10.1371/journal.ppat.1009843.g002
Fig 3. FLCs increase in urine in patients with acute PUUV-HFRS. (A) The concentration of FLCs and total protein levels were measured in sequential urine
samples from the same patients as in Fig 2A and 2B. The protein concentrations in urine was normalized based on total urinary volume produced during an
overnight ~8h collection. The kinetics of κFLC (in B) and λFLC (in C) secretion in urine and in circulation (serum samples, same data as in Fig 2A) were
compared. The medians ± interquartile ranges are shown.
https://doi.org/10.1371/journal.ppat.1009843.g003
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infiltrated plasma cells in PUUV-HFRS predominantly localized to the interstitial space (Fig
4A), which is consistent with the typical diagnosis of acute tubulointerstitial nephritis in
PUUV-HFRS (S3 Table). These findings point out to strong localized plasma cell response in
acute PUUV infection, which could contribute to kidney clogging by inducing high local Ig
and FLC concentrations. In addition, local production of FLCs in the kidneys could explain
the lack of correlation between urinary FLC and serum FLC levels. The number of plasma cells
in the kidneys positively correlated with the number of CD68+ and CD14+ cells (S2B Fig),
which were previously analyzed from the same sample set [21] and likely represented macro-
phages and infiltrating monocytes, respectively. These results suggest a direct link between
plasma cells and general inflammatory response in the kidneys during acute HFRS.
Elevated levels of circulating plasmablasts (PBs) in acute PUUV
The observed infiltration of plasma cells into the kidneys suggests an extensive B cell activation
during acute PUUV-HFRS. An increase in the amount of circulating PBs, the plasma cell pre-
cursors, occurs in ANDV-caused HPS [12]. Hence, we employed multiparametric flow cytom-
etry to assess the abundance of PBs in PBMCs collected over the course of PUUV-HFRS from
hospitalization to convalescence. Cells representing other than B cell lineage (CD3, CD14,
CD56 and CD66) were removed through gating (S5 Fig) prior to dimensionality reduction
with the use of unsupervised clustering methods (UMAP and FlowSOM). Cells clustered into
10 populations, of which seven represented CD19+ B cells. The frequencies of the various B
cell populations differed dramatically in acute (4–10 aof) vs. convalescent (11–50 aof) phase of
Fig 4. Plasma cells infiltrate kidneys during acute PUUV-HFRS. Sections from archival kidney biopsies of acute PUUV-HFRS or from patients with a
kidney disease of another etiology were stained for κ or λ light chains by immunohistochemistry. (A) Representative images of κ and λ light chain staining
of a patient with acute PUUV-HFRS and one patient with another cause of kidney dysfunction (glomerulonephritis) as control, showing the presence of
infiltrating plasma cells in kidneys during acute PUUV-HFRS. (B) Quantification of the number of plasma cells in non-PUUV and acute PUUV-HFRS
(n = 37–38 for non-PUUV controls and 32–35 for PUUV-HFRS). The medians across groups were compared by Mann-Whitney test and significant
differences reported as � = p< 0.05 and ��� = p< 0.001. The bars indicate medians + interquartile ranges.
https://doi.org/10.1371/journal.ppat.1009843.g004
PLOS PATHOGENS Hantavirus infection induces free light chains
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009843 August 11, 2021 10 / 21
PUUV-HFRS (Fig 5A). Based on cell surface expression of CD27 and CD38 markers, as well as
intracellular Ig isotype expression, three populations were identified as PBs (pop1 = IgG+ PBs,
pop4 = IgM+ PBs and pop5 = IgA+ PBs), whereas the other four populations probably repre-
sented naïve and memory B cell subsets (Fig 5B). Next the abundance of CD19+/CD27+/
CD38+++ PBs (S5 Fig shows the gating strategy for representative acute and recovery phase
samples) was normalized to the total number of PBMCs in the sample (Fig 5C). We observed a
significant expansion of PBs in the acute stage (4–10 days aof) as compared to the samples
drawn at recovery (at 31–50 days aof). The median frequency of PBs fluctuated extensively
during the acute stage from 0.5% to 1.5% of all PBMCs. These findings indicate a marked B
Fig 5. Plasmablast frequencies increase in the circulation of patients with acute PUUV-HFRS. A) UMAP and FlowSOM analysis was used to identify
different cell populations in single live PBMCs, from which CD3, CD14, CD56 and CD66 positive cells were removed by conventional gating (gating strategy
shown in S2 Fig). The distinct CD19+ cell populations are shown by specific colors, whereas the CD19- populations are merged as light grey color in the plot.
(B) Heatmap showing the relative mean MFI of CD27, CD38, IgM, IgG and IgA in different CD19+ cell populations. (C) The frequencies of CD19+ PBs out of
total number PBMC used for flow cytometry analysis (gating shown in S2 Fig) were calculated for each sample at indicated days post onset of fever. Data is
obtained from 13 PUUV-HFRS patients. (D) The frequencies IgA+, IgM+ and IgG+ PBs in relation to the total number of PBs for each sample were calculated
and plotted similarly as in C. (E) EDTA-plasma from acute (1st day of hospitalization, 5–8 days post onset of symptoms), early recovery (15–30 days post onset
of symptoms) and full recovery (180 days post onset of symptoms) were subjected to total IgA, IgM and IgG ELISA (n = 14 for all groups). Significant
differences between each indicated time point to full recovery (31–50 days post onset of symptoms in C and 180 days post onset of symptoms in E) were
calculated using generalized estimating equations. �p< 0.05, ��p< 0.01, ���p< 0.001.
https://doi.org/10.1371/journal.ppat.1009843.g005
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cell activation during acute PUUV-HFRS, paralleling the observations on acute HPS patients
[12].
Further analysis revealed the acute-phase PBs to be distributed as ~55% being IgA+, ~35%
IgG+, and ~10% IgM+, with no statistically significant differences in their relative frequencies
between acute-phase and recovery samples (Fig 5D). However, lower levels of IgM+ PBs (~5%)
were present at the late acute phase (10 and 11–15 days aof) versus convalescence (~15%, 31–
50 days aof). The distribution of plasmablast Ig isotypes during PUUV infection was similar to
healthy controls [22], indicating a polyclonal “innate”- type B cell activation rather than expan-
sion of virus-specific B cell clones. The findings further demonstrate that IgA+ and IgM+ PBs
are relatively more abundant than IgG+ PBs in the early acute phase as compared to early and
full recovery. To estimate the impact of PB expansion (i.e. B cell activation) on Ig production,
we measured the concentrations of circulating IgA, IgM, and IgG. The acute-phase samples
presented significantly elevated IgA and IgM levels, whereas the samples taken at early recov-
ery demonstrated elevated IgG levels, as compared to full recovery samples (Fig 5E).
PUUV infects B cells
Hantaviruses infect microvascular endothelial cells and macrophages in patients [3,23], but
their ability to infect B cells is currently unclear. To investigate if PUUV can directly infect B
cells, we inoculated PBMCs isolated from healthy volunteers with either “live” (PUUV) or
UV-inactivated PUUV (UV-PUUV). Flow cytometry analysis revealed PUUV N protein
(PUUV-NP) expression in both naïve (IgD+ CD27-) and memory (IgD- CD27+) B cells at 2
and 5 days post infection (dpi) (the gating strategy shown in Fig 6A). The PUUV- and
UV-PUUV-inoculated PBMCs analyzed at 2 dpi did not show statistically significant differ-
ences in the amount of PUUV-NP+ cells (Fig 6B). However, analysis at 5 dpi showed signifi-
cantly more PUUV-NP+ naïve B cells in PUUV, in contrast to UV-PUUV infected PBMCs
(Fig 6B), indicating virus replication. In addition, the number of PUUV-NP+ memory B cells
appeared to be elevated, although the difference was not statistically significant. To provide
additional evidence of the B cells’ ability to support PUUV replication, we inoculated enriched
B cells of healthy volunteers (enrichment by negative selection resulted in ~90% B cell purity
as assessed by CD19 expression, S6A Fig) with PUUV and UV-PUUV. Fluorescence micros-
copy revealed PUUV-NP expression in LC-positive B cells inoculated with PUUV, but not in
those inoculated with UV-PUUV (Fig 6C), confirming successful that PUUV can replicate in
B cells. Western blot served to assess productive PUUV replication, and showed increased
PUUV NP expression in enriched B cells inoculated with live PUUV versus UV-PUUV (S6B
Fig). Interestingly, western blot analysis also revealed increased production of FLCs by PUUV,
as compared to UV-PUUV, in B cells.
To study whether PUUV infection of B cells occurs in vivo, we analyzed PBMCs collected at
the acute and recovery phase of PUUV-HFRS using flow cytometry. Following the gating strat-
egy described in Fig 5A, with the exception of intracellular PUUV-NP staining instead of
whole Igs (gating for representative samples shown Fig 6D), we determined the mean frequen-
cies of PUUV-NP+ CD19+ (B cells) and CD19+CD38+++ cells (PBs). PUUV-NP+ cells during
the early acute stage displayed the highest cell counts (~0.6% out of CD19+ and ~0.5% of
CD38+++ cells at 2–5 days aof), which declined towards recovery and reached undetectable lev-
els at 30 days aof (Fig 6E). Interestingly, the data showed PUUV-NP+ cells to be almost exclu-
sively PBs (CD38+++ cells, Fig 6D and 6E). As shown earlier (Fig 5), approximately 30% of
CD19+ cells in the acute-phase samples (from 4–9 days aof) were CD38+++ (PBs), and the
amount of PBs returned to baseline levels (< 10%) at 30 days aof (Fig 6E). Similarly to the in
vitro infection experiments, PUUV-NP expression in patient B cells was detected also by
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Fig 6. PUUV infects B cells. (A, B) PBMCs from healthy volunteers were inoculated with live PUUV or UV-inactivated PUUV as a control at a multiplicity of 5
FFFU virus/PBMC and cultured for 2 or 5 days. Naïve (CD19+IgD+CD27-) and memory (CD19+IgD-CD27+) B cells were identified by multi-parametric flow
cytometry and, as an indication of PUUV infection, intracellular staining for PUUN using PUUN-specific AlexaFluor647-conjugated Mab 1C12 was included. (A)
An example of the gating strategy to detect PUUN+ naïve or memory B cells is shown. (B) The mean frequencies of PUUN+ cells out of total number of naïve or
memory B cells in inoculated PBMCs were compared between non-treated and PUUV or UV- PUUV inoculated groups with two-way ANOVA and Dunnett’s
multiple comparison tests. �p< 0.05, ��p< 0.01, ���p< 0.001. (C) B cells were isolated from healthy volunteer PBMCs, inoculated with live PUUV or UV-PUUV
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immunofluorescence analysis (Fig 6F). Taken together these results suggest that PUUV can
infect various B cells subsets in vitro and in patients.
PUUV induces secretion of FLCs from B cells
To assess whether PUUV infection induces B cell activation and FLC production, we inocu-
lated B cells enriched from PBMCs of healthy volunteers with PUUV and UV-PUUV, and
mock-infected cells as an additional control. Toll-like receptor 9 (TLR9) ligand CpG served as
a positive reference for B cell activation. For comparison, we inoculated a reference set of B
cells with Sendai virus (SeV, a potent immune stimulant) and Sindbis virus (SINV, not associ-
ated with B cell activation) at multiplicity of infection (MOI) comparable to PUUV inoculum.
At day 6 post treatment, we measured κFLC, λFLC, and whole Ig (A, M and G classes) levels
from the B cell supernatants, and quantified the amount of IgA, IgM or IgG secreting B cells
(antibody secreting cells; ASCs) by Elispot. PUUV and SeV infections, as well as CpG treat-
ment, induced significantly elevated κFLC and λFLC levels (~2000–4000 vs. ng/l for κ, ~1000–
2000 vs. ng/l for γ; Fig 7A) as compared to both mock infection and UV-PUUV inoculation.
In addition, the stimulation with CpG and/or the infection with PUUV or SeV all induced, as
compared to mock-infected B cells, an approximately two-fold increase in the secretion of sol-
uble IgA (~1–2 vs. 0.8 μg/ml), IgM (1–1.5 vs. 0.75 μg/ml) and IgG (~1.5 vs. 0.75 μg/ml). Similar
induction did not occur with UV-PUUV or SINV-inoculated B cells (Fig 7B). Expectedly,
based on PB distribution (Fig 5C), PUUV induced ASCs of all the analyzed Ig classes (Fig 7C
and 7D). Interestingly, while CpG appeared as more potent inducer of IgM+ and IgG+ ASCs,
PUUV showed highest level of IgA+ ASCs (Fig 7D).
To conclude, the data show PUUV infection to activate B cells, which results in a polyclonal
Ig response involving not only intact IgA, IgM and IgG, but also κFLC and λFLC. The fact that
UV-PUUV did not produce a similar effect suggests that B cell activation results from direct
viral replication. The observation of increased FLC levels in supernatants of SeV infected and
CpG stimulated cells points to FLC secretion to be a typical outcome in B cell differentiation
towards ASCs. Curiously, PUUV appeared as the most potent inducer of ASCs secreting IgA.
Discussion
Hantaviruses can cause either HFRS or HPS when transmitted to humans, and increasing evi-
dence suggests that the pathogenesis of hantavirus infection in humans is due to intense activa-
tion of the immune system, rather than direct virus-induced damage. In this study, we show a
marked increase in serum κFLC and λFLC levels in both acute HFRS and HPS while the κFLC/
λFLC ratio was elevated specifically in HFRS. Further studies on HFRS revealed the presence of
renal plasma cell infiltration and urinary FLC secretion, which point out towards local, exces-
sive humoral responses. These findings coincided with an increased frequency of circulating
PBs in HFRS, a likely source of elevated serum FLCs in both HFRS and HPS. Furthermore, we
showed PUUV to infect B cells directly, resulting in proliferation and FLC secretion in vitro.
and cultured for 5 days at 37˚C. Cells were spun down on glass slides and fixed, permeabilized and stained for PUUN (as a marker of infection) and light chains
(LC, as markers of B cells) expression by immunofluorescence. The images are representative of experiments performed using two PBMC donors. (D, E) PBMCs
obtained from patients with PUUV infection were stained for PBs similarly as in Fig 5, except that the Ig-specific Abs were omitted and intracellular staining of
PUUN was included using PUUN-specific AlexaFluor647-conjugated Mab 1C12. PUUN+ PBs were detected from CD19+ cells (gated similarly as in Fig 5) by
plotting PUUN vs. CD38. (D) Representative plots from acute and recovery stage PUUV patient PBMC samples are shown. (E) The frequency of PUUN+ cells
(above plot) in CD19+ cells (total B cells) and CD19+CD38+++ cells (PBs), together with CD38+++ cells in CD19+ cells (PBs of total B cells; below plot), were
calculated from sequential acute to recovery stage of PUUV-HFRS PBMC patient samples. Means ± standard errors are shown. (F) Patient B cells were isolated
from PBMCs, spun down on glass slides and fixed, permeabilized and stained for PUUN (as a marker of infection) and light chains (LC, as markers of B cells)
expression by immunofluorescence. The scale bars (in C and F) correspond to 10μm.
https://doi.org/10.1371/journal.ppat.1009843.g006
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The findings suggest that B cell activation via hantavirus infection could play a role in the path-
ogenesis of hantavirus-caused diseases.
The FLC concentrations in hantavirus patient serum exceeded the normal serum reference
values: κFLC (3.3–19.4 μg/ml) and λFLC (5.7–26.3 μg/ml) [24]. However, the κFLC/λFLC ratio
remained within the normal range (0.26–1.65, [24]) in both acute HFRS and HPS, suggesting
that the increase in serum FLCs in acute hantavirus infection is a result of polyclonal B cell
activation rather than proliferation of single B cell clone. The kidney mediates FLC clearance,
therefore serum FLCs increase as kidney function declines [24]. Thus, the higher κFLC/λFLC
ratio in patients with HFRS compared to HPS patients is likely a direct consequence of AKI,
further supported by strong positive correlation between serum FLC levels and maximum
serum creatinine, an indicator of the severity of AKI.
Clonal FLCs exert renal pathogenesis in multiple ways, including fibril or deposit forma-
tions that affect the glomeruli, induce epithelial cell disorders, or cast in the tubular network
[25]. Our analysis of PUUV patients’ kidney biopsies demonstrated significant infiltration of
plasma cells in the renal interstitium. Given that plasma cells produce LCs in excess over heavy
chains, secreting the surplus as FLCs [26]: this observation together with the increased urinary
FLC levels before the peak in circulating serum FLCs (i.e. lack of correlation between urinary
Fig 7. PUUV activates B cells to produce FLCs and whole Igs. B cells were enriched from blood of 3 healthy volunteers and infected with live or UV-inactivated
purified PUUV, together with Sendai and Sindbis viruses, for comparison (multiplicity of infections for all viruses equals 1). The TLR9 agonist CpG and no
treatment were used as a positive and negative controls for B cell activation, respectively. After culturing for 8 days, kappa and lambda FLCs in (A) and IgA, IgM
and IgGs in (B) were measured from cell supernatants. Remaining cells were subjected to IgA, IgM and IgG-specific antibody secreting cell (ASC) quantification
using Elispot. IgA+ and IgM+ ASCs were simultaneously detected in one well, using AP-conjugated anti-IgA and HRP-conjugated anti-IgM Abs, and IgG+ ASCs in
a separate well using HRP-conjugated anti-IgG Ab. Representative Elispot images from one donor are shown in (C), and ASC quantification per input cell number
measured from all donors in (D). Significant differences of each treatment group, as compared to non-treated cells, were assessed using two-way ANOVA and
Dunnett’s multiple comparison tests. �p< 0.05, ��p< 0.01, ���p< 0.001.
https://doi.org/10.1371/journal.ppat.1009843.g007
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and serum FLCs), might suggest a local FLC production in the kidneys, which could contrib-
ute to AKI in HFRS. While highly speculative, similar plasma cell infiltration and FLC produc-
tion could occur in the lungs instead of kidneys in acute HPS. Interestingly, increased levels of
FLCs associate with different lung disorders [27].
Although previously considered functionally insignificant bystander products of B cell
activity, FLCs have recently gained attention as mediators of extrarenal manifestations such
mast cell hypersensitivity reactions [28] and influencing the life span of neutrophils [29]. The
latter is particularly interesting in terms of hantavirus pathogenesis since neutrophil activation
does correlate with disease severity in HFRS [6,30], and local expression of the neutrophil che-
moattractant interleukin-8 (IL-8) as well as other neutrophil-related proteins have been
observed in patient kidneys [6]. Interestingly, FLCs induce IL-8 and recruit neutrophils to the
lungs in murine models of chronic obstructive pulmonary disease [31] and similar phenomena
could be envisaged to take place also in kidneys and lungs during acute HFRS and HPS,
respectively.
PUUV patient samples collected during the acute phase of illness contained significantly
elevated levels of circulating PBs, which returned to normal range in recovery. PBs, present in
the blood circulation, are extensively proliferating intermediates of activated B cells, differenti-
ating towards becoming plasma cells [32]. The fact that increased level of circulating PBs coin-
cided with the increased FLC concentration proposes PBs to play a role in their upregulation.
We further speculate that the observed plasma cell infiltration to the kidneys might be due to
an expansion of the PB population. This PB response in patients led to elevated levels of circu-
lating total IgA, IgM and IgG during acute and early recovery stages. The PBs collected in the
acute and recovery phases did not show significant differences in the frequencies of IgA+, IgG+
or κLC+ cells. However, the IgM+ PBs frequency diminished towards the late acute/early
recovery period, suggesting class-switched PBs to dominate at the later stages of the disease.
We conjecture that, in addition to insufficient renal clearance, PBs/plasma cells account for
the elevated FLC levels in the circulation of patients with acute PUUV-HFRS. A massive and
transient circulating PB response also occurs in acute ANDV-caused HPS [12]. The ANDV
infection-induced PBs showed specificity towards both viral and host antigens, suggesting a
polyclonal bystander B cell activation. Along the same idea, we have earlier shown that EBV-
specific memory T cells are boosted after PUUV hantavirus infection [33] and recently showed
heterologous boosting of nonrelated immunity during acute PUUV [34], indicating that
immune responses towards hantaviruses are not entirely specific. Garcia et al. reported also
the HPS patients to show a significantly elevated frequency of IgA+ PBs [12], whereas our
results display similar levels of IgA+ PBs in PUUV patients.
Analysis of PUUV patients’ PBMCs revealed PBs as positive for PUUV antigen, with the
fraction of positive PBs waning down towards convalescence. The finding suggests productive
infection of B cells that could drive their differentiation into PBs. Supporting the hypothesis,
we found purified B cells to be permissive for PUUV infection in vitro, leading to B cell prolif-
eration and secretion of both intact Igs and FLCs. Thus, the findings suggest that the observed
PB/plasma cell response in acute PUUV-HFRS to be a T cell-independent (TI) “innate-like”
response, rather than T cell-dependent (TD) class-switched virus-specific response that occur
in germinal centers. If this is the case, the virus-induced activation of B cells is highly poly-
clonal rather than solely virus-targeted, and indeed Garcia et al. found PB responses towards
non-virus-related antigens in acute HPS [12]. An overt non-specific polyclonal B cell response
could explain the massive FLC production seen in HFRS and HPS.
Acute polyclonal PB response occurs also in other viral infections (reviewed by [35])
including those caused by dengue flavivirus (DENV) [36]. The pathogenesis of DENV bears
similarities to hantavirus diseases, in which vascular leakage and hemorrhages are key clinical
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findings, while renal insufficiencies are also common, although less reported [37,38]. The PB
response in acute DENV can be as high as 80% of all CD19+ B cells, constituting 30% of total
PBMCs [39] and associating with disease severity [40]. Similarly as shown in the current study
for PUUV, B cells can support DENV infection in vitro that results in B cell activation and pro-
duction of polyreactive Abs [41], with the majority of DENV RNA within patient PBMCs
being associated with naïve B cells [42]. Taken together, it seems that the role of FLCs in the
pathogenesis of hemorrhagic fevers, and infectious diseases in general, is not yet fully
recognized.
Supporting information
S1 Fig. Sequential patient samples used in this study. The number of samples at each day
post onset of fever are indicated for PBMC, serum and urine obtained from PUUV-caused
HFRS patients.
(TIF)
S2 Fig. Correlograms of clinical and laboratory parameters in acute hospitalized PUUV-
caused HFRS. Spearman correlation analysis of serum κFLC, λFLCs and their ratio (in A) and
κ- and λ-LC specific plasma cells (PC) in kidneys (in B) with clinical and laboratory parame-
ters are shown. The color of the circles indicates the value of Spearman correlation coefficients
as depicted in the legend on the right and increasing size of the circles indicate decreasing
p-value (statistical significance is reported as � = p< 0.05, �� = p< 0.01, ��� = p< 0.001 and
���� = p< 0.0001). Creatinine, leukocytes, C-reactive protein (CRP), interleukin (IL)-6 and
thrombocytes correspond to maximum and minimum values in blood during hospital stay,
respectively. Hosp. LOS = Length of stay in hospital. cUAlb = Overnight urinary albumin
excretion. CD68, CD14, CD16 and HLA-DR correspond to the extent infiltration of CD68+,
CD14+, CD16+ and HLA-DR+ leukocytes in kidneys.
(TIF)
S3 Fig. Association of serum FLCs with disease severity in hantavirus-caused diseases. (A)
Serum κ and λ FLC levels in PUUV-caused HFRS patients with and without the need of dialy-
sis (n = 26 and n = 4) and (B) ANDV-caused HPS patients stratified based on disease severity
(1 = with prodromal symptoms without respiratory involvement; 2 = mild to moderate respi-
ratory compromise without hemodynamic compromise; 3 = with severe respiratory insuffi-
ciency with hemodynamic compromise; 4 = with severe respiratory insufficiency with
refractory-to-treatment hemodynamic compromise, with a final fatal outcome). Statistically
significant differences assessed with Mann-Whitney test and reported as � = p< 0.05. The
bars indicate medians + interquartile ranges.
(TIF)
S4 Fig. The concentration of FLCs (κ in A and λ in B) in urine samples collected at indicated
days post onset of fever from patients with acute PUUV-HFRS (n = 13) were correlated to
total urinary protein levels using Spearman’s rank correlation coefficient. Non-linear associa-
tion between parameters is depicted by the red line.
(TIF)
S5 Fig. Gating strategy for the detection of plasmablasts in the circulation of patients with
acute PUUV-HFRS by multi-parametric flow cytometry. After gating on PBMCs (SSC-A vs.
FSC-A), single cells (FSC-H vs. FSC-A) and CD19+ B cells (CD3, CD14, CD56, CD66 vs.
CD19), were identified as CD27+CD38++ cells (CD27 vs. CD38). IgM+ and IgA+ PBs were
gated from the total PB fraction (IgM vs. IgA) and IgG+ PBs (SSC-A vs. IgG) from the
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IgM-IgA- fraction. Representative plots for an acute and recovery stage PUUV-HFRS are
shown.
(TIF)
S6 Fig. Replication of PUUV in B cells. B cells were isolated from healthy volunteer PBMCs
by negative selection and a representative histogram of the percentage of CD19+ B cells in the
isolated fraction as assessed by flow cytometry is shown in (A). (B) Isolated B cells were left
untreated, activated with CpG (1 μM) or infected with live (5 FFFU / cell) or UV-inactivated
PUUV and subjected to non-reducing western blot at 5 days post infection. The viral N protein
and κLC expressions (both green) were detected by specific Abs produced in mouse or goat,
respectively. A rabbit Ab to actin (red) served as a protein loading control. Free and heavy
chain (HC)-associated light chains (LC) are indicated.
(TIF)
S1 Table. Individual PUUV-HFRS patient characteristics from which serum samples at 1st
day of hospitalization was included in this study.
(DOCX)
S2 Table. Individual ANDV-HPS patient characteristics from which serum samples were
included in this study.
(DOCX)
S3 Table. Individual PUUV-HFRS and control patient characteristics from which kidney
biopsies were included in this study.
(DOCX)
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6. Strandin T, Mäkelä S, Mustonen J, Vaheri A. Neutrophil Activation in Acute Hemorrhagic Fever With
Renal Syndrome Is Mediated by Hantavirus-Infected Microvascular Endothelial Cells. Front Immunol.
2018; 9:2098. https://doi.org/10.3389/fimmu.2018.02098 PMID: 30283445
7. Mackow ER, Gorbunova EE, Gavrilovskaya IN. Endothelial cell dysfunction in viral hemorrhage and
edema. Front Microbiol. 2014; 5:733. https://doi.org/10.3389/fmicb.2014.00733 PMID: 25601858
8. Sironen T, Klingström J, Vaheri A, Andersson LC, Lundkvist A, Plyusnin A. Pathology of Puumala han-
tavirus infection in macaques. PLoS One. 2008; 3(8):e3035. https://doi.org/10.1371/journal.pone.
0003035 PMID: 18716663
9. Hepojoki S, Kareinen L, Strandin T, Vaheri A, Holthöfer H, Mustonen J, et al. Urine and Free Immuno-
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